Cochrane Abstracts
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Preoperative Chemoradiation Versus Radiation Alone for Stage II and III Resectable Rectal Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433960/1/Preoperative_chemoradiation_versus_radiation_alone_for_stage_II_and_III_resectable_rectal_cancer.
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433960/1/Preoperative_chemoradiation_versus_radiation_alone_for_stage_II_and_III_resectable_rectal_cancer. Accessed January 19, 2025.
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433960/1/Preoperative_chemoradiation_versus_radiation_alone_for_stage_II_and_III_resectable_rectal_cancer
Preoperative Chemoradiation Versus Radiation Alone for Stage II and III Resectable Rectal Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433960/1/Preoperative_chemoradiation_versus_radiation_alone_for_stage_II_and_III_resectable_rectal_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
ID - 433960
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433960/1/Preoperative_chemoradiation_versus_radiation_alone_for_stage_II_and_III_resectable_rectal_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
